| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase III comparison of two toremifene dosesto tamoxifen in postmenopausal women with advanced breastcancer
|
Michael Gershanovich
|
|
1997
|
45 |
3 |
p. 251-262
12 p.
|
artikel
|
| 2 |
A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer
|
Gershanovich, Michael
|
|
1997
|
45 |
3 |
p. 251-262
|
artikel
|
| 3 |
Bone marrow fibroblastic progenitors in patients with advancedbreast cancer
|
Norma A. Chasseing
|
|
1997
|
45 |
3 |
p. 211-218
8 p.
|
artikel
|
| 4 |
Bone marrow fibroblastic progenitors in patients with advanced breast cancer
|
Chasseing, Norma A.
|
|
1997
|
45 |
3 |
p. 211-218
|
artikel
|
| 5 |
Consistency of patient- and doctor-assessed cosmetic outcome afterconservative treatment of breast cancer
|
Holli Kaija
|
|
1997
|
45 |
3 |
p. 225-228
4 p.
|
artikel
|
| 6 |
Consistency of patient- and doctor-assessed cosmetic outcome after conservative treatment of breast cancer
|
Kaija, Holli
|
|
1997
|
45 |
3 |
p. 225-228
|
artikel
|
| 7 |
Eicosapentaenoic acid and sulphur substituted fatty acid analoguesinhibit the proliferation of human breast cancer cells in culture
|
Farzaad Abdi-Dezfuli
|
|
1997
|
45 |
3 |
p. 229-239
11 p.
|
artikel
|
| 8 |
Eicosapentaenoic acid and sulphur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture
|
Abdi-Dezfuli, Farzaad
|
|
1997
|
45 |
3 |
p. 229-239
|
artikel
|
| 9 |
Followup after 11 years update of mortalityresults in the Stockholm mammographic screening trial
|
Jan Frisell
|
|
1997
|
45 |
3 |
p. 263-270
8 p.
|
artikel
|
| 10 |
Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial
|
Frisell, Jan
|
|
1997
|
45 |
3 |
p. 263-270
|
artikel
|
| 11 |
Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients
|
Romeo Bascioni
|
|
1997
|
45 |
3 |
p. 205-210
6 p.
|
artikel
|
| 12 |
Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients
|
Bascioni, Romeo
|
|
1997
|
45 |
3 |
p. 205-210
|
artikel
|
| 13 |
Predictors of response to second-line endocrine therapy forbreast cancer
|
K.L. Cheung
|
|
1997
|
45 |
3 |
p. 219-224
6 p.
|
artikel
|
| 14 |
Predictors of response to second-line endocrine therapy for breast cancer
|
Cheung, K.L.
|
|
1997
|
45 |
3 |
p. 219-224
|
artikel
|
| 15 |
Prognostic significance of estrogen receptors in 405 primarybreast cancers: a comparison of immunohistochemical and biochemical methods
|
A. Molino
|
|
1997
|
45 |
3 |
p. 241-249
9 p.
|
artikel
|
| 16 |
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods
|
Molino, A.
|
|
1997
|
45 |
3 |
p. 241-249
|
artikel
|
Tijdschrift beschrijving